Tag Archives: breakthrough drugs

New research: Acquisitions, buybacks and shareholder-driven manoeuvre threaten public access to breakthrough drugs

CAMBRIDGE, 28-Jul-2016 — /EuropaWire/ — An analysis of a new drug’s journey to market, published today in the BMJ, shines a light on financial practices that see some major pharmaceutical companies relying on a cycle of acquisitions, profits from high … Read the full press release